mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.8 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.8 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |